Scientech Research’s Grace Therapeutics GRCE Stock Holding History
Bought
Maintained
Sold
Other funds holding GRCE
Scientech Research's GRCE Position: Q2 2026 in Review
Scientech Research opened a new position in Grace Therapeutics (GRCE) in Q2 2026: 10,184 shares worth $23.1K. The stake represents 0.02% of the portfolio and ranks #211 among its holdings.
33 funds tracked by Wall St. Rank hold GRCE as of Q2 2026.
- Scientech Research held 10,184 shares of Grace Therapeutics worth $23.1K as of Q2 2026.
- Grace Therapeutics was a new Scientech Research position in Q2 2026.
- Grace Therapeutics made up 0.02% of Scientech Research's portfolio in Q2 2026, its #211 holding.
- 33 funds tracked by Wall St. Rank held Grace Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.